Release – Comstock Announces Full Year 2021 Results



Comstock Announces Full Year 2021 Results

Research, News, and Market Data on Comstock Mining

 

Unveils Bioleum™ Breakthrough; A Carbon Neutral Crude Oil Capable of Replacing Fossil Crude

VIRGINIA CITY, NEVADA, MARCH 29, 2022 – Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its 2021 results, summary of transactions completed in 2021, and our new business outlook.  

Selected Strategic Highlights

  • Approved a new strategy with a mission of enabling systemic decarbonization and a vision of a net zero carbon world.
  • Acquired Comstock Innovations, formerly Plain Sight Innovations, with a portfolio of intellectual property that contributes to global decarbonization by efficiently converting massive supplies of unused and under-utilized woody-biomass resources into cellulosic ethanol, renewable diesel, sustainable aviation fuel, and other drop-in fuels. 
  • Acquired LINICO Corporation and a developing portfolio of technologies that contribute to global decarbonization by efficiently converting a diverse array of lithium-ion batteries (“LIBs”) into electrification products, including lithium, graphite, nickel, cobalt, copper, and cathode active materials (“CAMs”). 
  • Acquired Comstock Engineering, formerly Renewable Process Solutions, whose principals built twenty six biofuel refineries in the last fifteen years and managed multiple industrial-scale projects from construction to commissioning.
  • Established and integrated new leadership, including Kevin Kreisler, President and Chief Financial Officer, William McCarthy, Chief Operating Officer, David Winsness, Chief Technology Officer, and Rahul Bobbili, Chief Engineer.
  • Advanced Cellulosic Technology.  Our cellulosic technologies can convert woody biomass into renewable fuels at extraordinary yields, including cellulosic ethanol and Bioleum™ – a remarkable new form of carbon neutral crude oil capable of replacing fossil crude for use in producing renewable diesel, aviation, and other drop-in fuels.
  • Advanced Electrification Technology.  Our electrification technologies crush, separate, and condition every class of lithium-ion battery (“LIB”) feedstock together with their host devices and other electrification residues for unrivaled throughput and flexibility, and then – in contrast to any known competing process, immediately extract lithium to produce unique “black mass” metal powders that are cleaner and far more concentrated than competing products.
  • Advanced Monetizing Non-Strategic Assets. Our announced transactions for certain mineral and other properties now total over $25 million, including expected 2022 proceeds from Tonogold, Sierra Springs and others.  

Selected Financial Results

  • Total assets nearly tripled to $126,954,632 during 2021, as compared to $43,123,562, at December 31, 2020. Net equity also nearly tripled to $92,970,522 during 2021, as compared to $31,779,206  at December 31, 2020.
  • Operating loss of $6,405,921 as compared to an operating loss of $5,474,261 for 2020, primarily resulting from increased administrative expense from acquisitions, increased personnel, and higher research and development costs.
  • Full year 2021 net loss of $24,583,620 and $(0.49) per share, as compared to full year 2020 net income of $14,931,970 and $0.49 per share. The results in each year were driven by non-routine transactions, including goodwill impairments, changes in fair values of derivatives, and gains on sales of non-strategic assets. 
  • Debt was $4,486,256 million on December 31, 2021, representing unsecured promissory notes.
  • Cash and equivalents were $5,912,188 on December 31, 2021.
  • Outstanding common shares were 67,707,832 at March 28, 2022, and 71,207,832 at December 31, 2021.

“Our operating results reflect our investments in technology, people, and the increased research and development focus during the year, as we integrated the transactions necessary to build the foundation for growth,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. “Our investments during the year are already yielding breakthrough advancements in technology, and our team is making remarkable progress.”

Enabling Systemic Decarbonization – Cellulosic Fuels

The Company previously announced its plans to build, own, and operate a fleet of advanced carbon neutral extraction and refining facilities, with the goal of generating over $16 billion in revenue on an annualized basis by 2030. The Company has now formed a renewable fuels subsidiary, Comstock Fuels, that will efficiently convert wasted, unused, widely available, and rapidly replenishable woody biomass into advanced cellulosic fuels, unlocking vast quantities of historically underutilized feedstocks. These fuels work in existing infrastructure, depots, fueling stations, vehicles, and anything that burns fossil fuels. Just one of our biorefineries can produce over 100 million gallons of biofuel per year, including over 70 million gallons of cellulosic ethanol and 30 million gallons of renewable diesel from just 1 million metric tons of woody biomass per year. 

“The scale of the financial and environmental impact that we can enable with our technologies is staggering,” continued De Gasperis. “There isn’t a technology on Earth that can absorb carbon from the atmosphere as quickly as trees, or that can offset as much fossil emissions from the 1.5 billion cars and trucks on today’s roads faster than by burning renewable fuels instead of fossil fuels.  In this context, we have struck massive untapped supplies of carbon neutral oil that are hidden in plain sight.”

Enabling Systemic Decarbonization – Electrification Products

Electrification and continued advancements in energy storage are vitally necessary to reduce reliance on fossil fuels while shifting to and increasing use of renewable fuels. LiNiCo holds the rights to a portfolio of innovative processes that efficiently crush and separate LIBs, extract lithium, nickel, cobalt, and graphite, and reuse the recovered metals to produce 99% pure CAMs. These technologies give LiNiCo and its existing 137,000 square foot battery metal recycling facility differentiating competitive advantages, including the ability to process upwards of 100,000 tons of LIBs per year into an array of new products.

According to International Energy Agency (“IEA”), there were more than 10 million electric vehicles (“EVs”) on the road in 2020, with new EV registrations increasing by 41% over 2019 and another 140% during the first quarter of 2021. Meeting the increased EV demand is estimated to require about five times more lithium carbonate equivalent (“LCE”) than the entire lithium mining industry produces today. The world is clearly focused on further accelerating electrification to reduce reliance on fossil fuels, creating and driving this extraordinary demand for lithium, as well as nickel, cobalt, and other critical electrification resources. The push to electrify is so urgent that the Biden Administration recently invoked the Defense Production Act to develop increased lithium production capabilities in the United States.

“Our technologies are meeting the realities of this demand shortfall by extracting lithium first, immediately and efficiently, thereby enabling profitability at the earliest stages of production. The combination of that capability with the breadth of our feedstock acceptance capabilities positions our LIB recycling business to contribute billions to our enterprise value just based on the existing valuations of comparable public companies,” continued De Gasperis.

The Company is currently building commercial pilot scale facilities for LIBs and is preparing to commence operations at its state-of-the-art battery metal recycling facility later this year. The Company has already made significant strides in forging new cellulosic revenue and licensing streams, and is currently finalizing definitive agreements and timeframes, which will be shared soon. The Company has also made meaningful progress towards completing the monetization of its non-strategic assets as quickly as possible, while funding its businesses and limiting management’s focus to the renewable objectives outlined above.

De Gasperis concluded: “We look forward to our next communication and seeing those of you who can attend this year’s Annual General Meeting on May 26, 2022, where we plan on presenting our business plans and near-term revenues. We are extraordinarily focused on the renewable energy businesses that most impact our stakeholders in 2022 and beyond.”

About Comstock Mining Inc.

Comstock Mining Inc. (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting massive supplies of under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Forward-Looking Statements

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future industry market conditions; future explorations or acquisitions; future changes in our exploration activities; future changes in our research and development; future prices and sales of, and demand for, our products and services; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land sales; investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; and future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, taxes, earnings and growth. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in reports that we file with the Securities and Exchange Commission, including Item 1A, “Risk Factors” in our most recently-filed Annual Report on Form 10-K and/or Quarterly Report on Form 10-Q, and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, mercury remediation and lithium, nickel and cobalt recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration or mercury remediation, metal recycling, processing or mining activities; costs, hazards and uncertainties associated with precious metal based activities, including environmentally friendly and economically enhancing clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment and cash generating mineral production; costs, hazards and uncertainties associated with mercury remediation, metal recycling, processing or mining activities; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; ability to achieve the benefits of business opportunities that may be presented to, or pursued by, us, including those involving battery technology, mercury remediation technology and efficacy, quantum computing and advanced materials development, and development of cellulosic technology in bio-fuels and related carbon-based material production; ability to successfully identify, finance, complete and integrate acquisitions, joint ventures, strategic alliances, business combinations, asset sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, lithium, nickel, cobalt, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related call or discussion constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

  Contact information:    
Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
www.comstock.inc
Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com
Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

For Retail Investors AMCs CEO Adam Aron May Have Been the Biggest Star at the Oscars



Image Credit: Image Credit: Twitter: @CEOAdam


AMC Entertainment’s Plot Twist Gets Even More Interesting to Investors

 

While on his way to the Oscars Sunday afternoon, the CEO of AMC Entertainment spoke on the phone while his driver navigated the vehicle to Hollywood’s “big night.” He was being interviewed by Reuter’s about AMC’s recent purchase and plans for future acquisitions. What Mr. Aron revealed as part of the company’s evolution demonstrates a complete rethinking of the AMC’s strengths and what they can do to reward investors.

AMC is sitting on a large cash position that could benefit investors better if deployed to serve those that have believed in the company and invested in it during the pandemic – covid19 challenged the entertainment industry. They are beginning to recognize their current potential; this includes being able to shop for and make strategic acquisitions. The make-up of companies they would look to get involved with are those that could benefit from AMC’s competence in the capital markets.

On March 15, AMC surprised many by announcing a $27.9 million investment for a 22%
stake in Hycroft
Mining Holding Corp (HYMC). This outlay initially met with some head-scratching as the investment in the Nevada-based gold mine didn’t naturally seem like a fit for a company operating 900 theaters. It was explained by the CEO that one of the company’s core competencies is navigating the capital markets, he evidenced this by pointing to its success after being left for dead by investors in 2020.  After just 10 trading days, AMC’s Hycroft purchase looks good. AMC bought Hycroft shares at $1.07, and it is trading this morning (March 29) at $2.44. Hycroft has since raised $139 million by selling stock to investors in a bid to strengthen its balance sheet and grow operations at its gold and silver mine.

AMC has “dry powder” of about $1.8 billion that came from selling stock during the meme stock and short squeeze frenzy.

 

 

In another Adam Aron interview held by CNBC the day after the Academy Awards, David Faber asked, “Is that the new core competence of AMC, to sort of use these meme-sters that you have to help turnaround the fortunes of a company because they’re willing to put money behind it?” “I think I have to say the answer is yes, and we proved it,” Aron responded.

This response on CNBC was not a surprise to investors that had read the Reuter’s interview where he said, “I’d like to think there will be more third-party external M&A announcements going forward…Transformational M&A is mandatory. Our shareholder base has given us capital to deploy with the clear expectation that we are… going to do exciting things with the money they entrusted to us”

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading



AMC is Thinking Outside the Box Office and Diversifying



AMC Theaters Now Accepts 4 Cryptocurrencies





Is it Game-Over for Meme Stock Investors?



SPACs and Potential Sellers are Successfully Thinking Outside the Box

 

Sources

https://investor.amctheatres.com/newsroom/news-details/2022/AMC-Entertainment-Holdings-Inc.-Announces-Significant-Investment-Buying-22-of-Hycroft-Mining-Holding-Corporation/default.aspx

https://www.reuters.com/business/exclusive-amc-ceo-says-more-meme-stock-powered-deals-are-coming-2022-03-28/

https://markets.businessinsider.com/news/stocks/amc-entertainment-meme-stock-price-ceo-plans-more-deals-ahead-2022-3?utm_medium=ingest

https://www.google.com/search?q=what+is+a+transformational+acquisition

 

Stay up to date. Follow us:

 

Release – BioSig Technologies Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services



BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services

News and Market Data on BioSig Technologies

 

The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals

Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced a new partnership agreement with Summit Blue Capital for implementing a leasing and finance program for the Company’s PURE EP™ System.

The Minneapolis-based Summit Blue Capital is a leader in equipment finance and leasing. It offers tailored leasing and financing solutions for its partners and clients in industries such as healthcare, manufacturing, hospitality, technology solutions, and more. Most notably, Summit Blue Capital specializes in simplifying the financing experience and finding solutions to advance commercial roll outs in the healthcare industry.

“We believe that partnering with Summit Blue Capital will have considerable benefits to our commercial plans. We intend to take advantage of the Summit team’s expertise, flexibility, and financial solutions as a leasing partner,” said Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc. “Summit Blue Capital came highly recommended by one of the largest money center U.S. financial institutions. We believe this relationship will help take friction out of the sales cycle and advance our timeline while allowing BioSig to get paid up front per installation. The team at Summit Blue Capital is expected to also help us launch a subscription-based revenue model for our software.”  

“The pathway to purchase is always of great consideration in the capital equipment forum. We anticipate that partnering with Summit Blue Capital will impact our ability to expedite PURE EP’s entrance into new electrophysiology labs across the United States,” commented Gray Fleming, Chief Commercial Officer of BioSig Technologies, Inc.

“BioSig has made significant improvements to the EP market, and they have a unique technology offering with their PURE EP,” said Adam Drill, President of Summit Blue Capital. “Summit Blue Capital is excited to partner with BioSig and execute on a strategic financing and leasing program that we believe will benefit their customer roll out and help position them as a leader in medical technology. We look forward to helping each other and building a solid foundation for the future.”

The PURE EP™ is an FDA 510(k) cleared non-invasive class II device that aims to drive procedural efficiency and efficacy in cardiac electrophysiology. To date, 75 physicians have completed more than 2,150 patient cases with the PURE EP™ System.

Clinical data acquired by the PURE EP™ System in a multi-center study at Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Mayo Clinic Jacksonville, and Massachusetts General Hospital was recently published in the Journal of Cardiovascular Electrophysiology and is available electronically with open access via the Wiley Online Library. Study results showed 93% consensus across the blinded reviewers with a 75% overall improvement in intracardiac signal quality and confidence in interpreting PURE EP™ signals over conventional sources.

About Summit Blue Capital
Summit Blue Capital is a national commercial finance business based in Minnesota. The Company specializes in custom vendor programs and lease lines-of-credit for companies across the United States. Summit Blue is a privately owned and independently operated finance company that serves all industries. For more information, visit www.summitbluecapital.com.

About BioSig Technologies
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The Company’s first product, PURE EP™ System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Forward-looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Andrew Ballou
BioSig Technologies, Inc.
Vice President, Investor Relations
55 Greens Farms Road
Westport, CT 06880
aballou@biosigtech.com
203-409-5444, x119

Source: BioSig Technologies, Inc.

Release – ISG Acquires AI Platform Solution Agreemint



ISG to Announce Third-Quarter Financial Results

Research, News, and Market Data on Information Services Group

 

Move strengthens ISG’s provider governance and risk management leadership

AI platform supports better negotiation and legal compliance of supplier contracts

Agreemint to be integrated into ISG GovernX® third-party management solution

STAMFORD, Conn.–(BUSINESS WIRE)– Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, said today it has acquired automated contracting solution Agreemint from its founders. Terms were not disclosed.

The AI-powered contracting platform brings important new capabilities to the market-leading ISG GovernX® vendor compliance and risk management solution and will be used by ISG to add value to future platform solutions now in development.

“Our SaaS-based GovernX platform has been one of our fastest-growing areas over the last two years, especially as large organizations seek to control costs and mitigate risk from their ever- expanding supplier ecosystems,” said Michael P. Connors, chairman and CEO of ISG. “Our acquisition of Agreemint creates the ultimate platform for enterprises to accelerate time to contract, keeping pace with their speed of technology adoption and partnership formation.”

The acquisition, Connors said, is part of ISG’s overall strategy to develop or acquire innovative SaaS-based platforms to complement its advisory business, bring more value to clients, and achieve consistent, double-digit recurring revenue growth.

Agreemint delivers automated contract authoring through a repository of legal positions to accelerate speed to contract. Its patented AI-powered smart functionality enables clients to negotiate better contracts by suggesting language proven to be legally compliant, governable and agreeable to both parties based upon analysis of previous contracting efforts. The software also anticipates language sticking points and includes a clause library that proposes pre-approved clause alternatives.

ISG has partnered with Agreemint since 2021 on solutions for several blue-chip ISG clients. Connors said the acquisition is a natural extension of that relationship and adding Agreemint software will make the ISG GovernX platform even more valuable for automating the entire contract lifecycle. GovernX has under management more than $60 billion of annual contact value, up 30 percent in the last year, across more than 10,000 client contracts, up 40 percent.

“Getting to ‘yes’ on a contract faster and more efficiently is what Agreemint is all about,” said Agreemint founder Peter Graham, who is joining ISG in an executive role. ”Agreemint’s AI-powered negotiating and contracting tools, coupled with GovernX’s extensive vendor compliance and risk management capabilities, makes GovernX the most complete solution for contract lifecycle management on the market today.”

For more information about ISG GovernX, visit this webpage. Further details about Agreemint can be found at agreemint.com.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 800 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

Source: Information Services Group, Inc.

Regulators May Add New Guard Rails to Temper Investment Risk



Image Credit: Image Image: Eric Ward (Flickr)


Retail Investors May Soon See More Safety Measures Including Coursework and Testing

 

The decline in cost, ease of use, and low cost of money have been positive for both investors and the brokerage industry. However, over the past few years, there has also been much greater use of what the regulators have referred to as “complex” investment products. These could include leveraged ETFs, options, or even structured interest rate products. It has been a while since groups of investors have been stung by derivative-based investments or others with risk that difficult to assess. Both FINRA and the SEC are considering whether the rules on availability should be reworked for both investors and those giving investment advice.

 

FINRA Taking Action

The Financial Industry Regulatory Authority (FINRA), is an authority working under the Securities and Exchange Commission (SEC) that writes and enforces rules that govern the activities of all registered broker-dealer firms and registered brokers in the U.S. It measures best practices, required practices, and protects the investing public against fraud and bad behavior of professionals.

FINRA recently released a regulatory notice to brokerage firms, reminding them of the risks of “complex” products and the legal obligations they have of making sure their investors are offered only suitable investment products. The notice said, “The number of accounts trading in complex products and options has increased significantly in recent years.” It went on to state that, “… important regulatory concerns arise when investors trade complex products without understanding their unique characteristics and risks.”

 


Not long ago, a live financial professional was the primary means of opening an account and learning of suitable investment products.  Image: Campus Production (Pexels)

FINRA, which is a self-regulating entity promoting and enforcing its rules, is now seeking comments on whether the current regulatory framework is adequate to protect investors. It noted that the old rules were adopted when most financial products were bought through direct contact with financial professionals, whereas today many of these products are bought and sold through self-direct trading platforms like Robinhood or other online brokers.

Defining “Complex”

FINRA describes a complex product in its regulatory notice as “a product with features that may make it difficult for a retail investor to understand the essential characteristics of the product and its risks (including the payout structure and how the product may perform in different market and economic conditions).” These can include “Mutual funds and ETFs that offer strategies employing cryptocurrency futures.” It also lists leveraged and inverse exchange-traded products, volatility-linked ETPs, structured products, and defined outcome ETFs, which offer exposure to the performance of a market.

“We continue to believe that the features of these products are such that they may be difficult for a retail investor to understand the essential characteristics of the products and their risks and, are, therefore complex,” FINRA said.

 


Access to all markets has become much easier. Image Credit: Techdaily.ca

 

Self-Directed Brokerage Platform

“These concerns may be heightened when a retail customer is accessing these products through a self-directed platform and without the assistance of a financial professional, who may be in a position to explain the key features and risks of the product to the retail investor,” FINRA expressed.

As part of the regulatory notice, FINRA opened a comment period to ask what additional requirements may be necessary to protect investors from a much faster and easier investing environment that includes new products without enough history to fully understand, particularly at the retail investor level. FINRA specifically asked as it relates to retail investors and self-directed platforms, “are additional guardrails needed for these types of platforms?”

Tests for Retail Transactions

FINRA may also be leaning toward retail investors needing to demonstrate adequate knowledge of the products they are risking money on.

The notice asks whether retail customers should be required “to demonstrate their understanding of those common characteristics and risks of complex products by completing a knowledge check and, if the customer fails to show the requisite knowledge, requiring the completion of a learning course and additional assessment?” In other words, a test, and perhaps a class.

Standard Options Trades

Most retail investors with a brokerage account never even considered the notion of trading options. That has changed.  FINRA writes that listed options trading volume has grown by 30% over 2020 and is almost 100% higher than in 2019.

“Similar to transactions in complex products, buying or selling options can be risky for retail investors who trade options without understanding their vocabulary, strategies and risks. Members should consider whether investors understand the various risks of trading options…” FINRA said.

Take-Away

Regulators, in any industry are wrestling with a rapidly changing world. The investment business has transformed rapidly with no-cost transactions, portable apps, and game-like point and execute functionality. FINRA is looking at its current safeguards and policies designed to protect the clients of those it regulates and is likely to make some adjustments after the comment period.

FINRA encourages all interested parties to comment on this request for comment. Comments must be received by May 9, 2022.

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading



SEC Investigates Digital Engagement Practices in Broker Apps



SEC Climate Change Disclosure Rules and Challenges





Why Some are More Vulnerable to Financial Scams



Bitcoin ETFs Again Experience Extreme Caution from SEC

 

Sources

https://www.finra.org/rules-guidance/notices/22-08

 

Stay up to date. Follow us:

 

Cocrystal Pharma (COCP) Scheduled to Present at NobleCon18 Investor Conference


Cocrystal Pharma provides a preview of their upcoming presentation at NobleCon18

NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

Free Registration Available – More Info


Research News and Advanced Market Data on COCP


NobleCon18 Presenting Companies

About Cocrystal Pharma

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Schwazze (SHWZ) Scheduled to Present at NobleCon18 Investor Conference


Schwazze CFO Nancy Huber provides a preview of their upcoming presentation at NobleCon18

NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

Free Registration Available – More Info


Research News and Advanced Market Data on SHWZ


NobleCon18 Presenting Companies

About Schwazze

Schwazze (OTCQX: SHWZ; NEO: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high- performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

BacTech Environmental (BCCEF) Scheduled to Present at NobleCon18 Investor Conference


BacTech President & CEO Ross Orr provides a preview of their upcoming presentation at NobleCon18

NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

Free Registration Available – More Info


News and Advanced Market Data on BCCEF


NobleCon18 Presenting Companies

About BacTech

BacTech is a proven environmental technology company, delivering effective and eco-friendly bioleaching and remediation solutions to commercial operations to process and recover preferred metals (gold, silver, cobalt, and copper) smartly and safely remove and transform harmful contaminants like arsenic into benign EPA-approved products for landfill. Tapping into numerous environmental and economic advantages of its proprietary method of bioleaching, BacTech uses naturally occurring bacteria, harmless to both humans and the environment, to neutralize toxic mining sites with high-pay potential. BacTech is publicly traded on the CSE under the symbol “BAC”; on the OTC as “BCCEF”; and the Frankfurt Stock Exchange as “0BT1”.

Perimeter Medical Imaging AI (PYNKF) Scheduled to Present at NobleCon18 Investor Conference


Perimeter Medical Imaging AI CEO Jeremy Sobotta provides a preview of their upcoming presentation at NobleCon18

NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

Free Registration Available – More Info


News and Advanced Market Data on PYNKF


NobleCon18 Presenting Companies

About Perimeter Medical Imaging AI

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated, investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” refers to the pink ribbons used during Breast Cancer Awareness Month.

Jaguar Health (JAGX) Scheduled to Present at NobleCon18 Investor Conference


Jaguar Health President & CEO Lisa Conte provides a preview of their upcoming presentation at NobleCon18

NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

Free Registration Available – More Info


News and Advanced Market Data on JAGX


NobleCon18 Presenting Companies

About Jaguar Health

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Jaguar Animal Health is a tradename of Jaguar Health. Jaguar Health’s wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human pharmaceuticals from plants harvested responsibly from rainforest areas. Our crofelemer drug product candidate is the subject of the OnTarget study, an ongoing pivotal Phase 3 clinical trial for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy. Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A. (f/k/a Napo EU S.p.A.), an Italian corporation established by Jaguar Health in Milan, Italy in 2021 that focuses on expanding crofelemer access in Europe.

Vox Royalty Corp. (VOXCF) Scheduled to Present at NobleCon18 Investor Conference


Vox Royalty CEO Kyle Floyd provides a preview of their upcoming presentation at NobleCon18

NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

Free Registration Available – More Info


News and Advanced Market Data on VOXCF


NobleCon18 Presenting Companies

About Vox Royalty

Vox is a high growth precious metals royalty and streaming company with a portfolio of over 50 royalties and streams spanning eight jurisdictions. The Company was established in 2014 and has since built unique intellectual property, a technically focused transactional team and a global sourcing network which has allowed Vox to become the fastest growing company in the royalty sector. Since the beginning of 2019, Vox has announced over 20 separate transactions to acquire over 45 royalties.

ISG Acquires AI Platform Solution Agreemint



ISG to Announce Third-Quarter Financial Results

Research, News, and Market Data on Information Services Group

 

Move strengthens ISG’s provider governance and risk management leadership

AI platform supports better negotiation and legal compliance of supplier contracts

Agreemint to be integrated into ISG GovernX® third-party management solution

STAMFORD, Conn.–(BUSINESS WIRE)– Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, said today it has acquired automated contracting solution Agreemint from its founders. Terms were not disclosed.

The AI-powered contracting platform brings important new capabilities to the market-leading ISG GovernX® vendor compliance and risk management solution and will be used by ISG to add value to future platform solutions now in development.

“Our SaaS-based GovernX platform has been one of our fastest-growing areas over the last two years, especially as large organizations seek to control costs and mitigate risk from their ever- expanding supplier ecosystems,” said Michael P. Connors, chairman and CEO of ISG. “Our acquisition of Agreemint creates the ultimate platform for enterprises to accelerate time to contract, keeping pace with their speed of technology adoption and partnership formation.”

The acquisition, Connors said, is part of ISG’s overall strategy to develop or acquire innovative SaaS-based platforms to complement its advisory business, bring more value to clients, and achieve consistent, double-digit recurring revenue growth.

Agreemint delivers automated contract authoring through a repository of legal positions to accelerate speed to contract. Its patented AI-powered smart functionality enables clients to negotiate better contracts by suggesting language proven to be legally compliant, governable and agreeable to both parties based upon analysis of previous contracting efforts. The software also anticipates language sticking points and includes a clause library that proposes pre-approved clause alternatives.

ISG has partnered with Agreemint since 2021 on solutions for several blue-chip ISG clients. Connors said the acquisition is a natural extension of that relationship and adding Agreemint software will make the ISG GovernX platform even more valuable for automating the entire contract lifecycle. GovernX has under management more than $60 billion of annual contact value, up 30 percent in the last year, across more than 10,000 client contracts, up 40 percent.

“Getting to ‘yes’ on a contract faster and more efficiently is what Agreemint is all about,” said Agreemint founder Peter Graham, who is joining ISG in an executive role. ”Agreemint’s AI-powered negotiating and contracting tools, coupled with GovernX’s extensive vendor compliance and risk management capabilities, makes GovernX the most complete solution for contract lifecycle management on the market today.”

For more information about ISG GovernX, visit this webpage. Further details about Agreemint can be found at agreemint.com.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 800 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

Source: Information Services Group, Inc.

BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services



BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services

News and Market Data on BioSig Technologies

 

The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals

Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced a new partnership agreement with Summit Blue Capital for implementing a leasing and finance program for the Company’s PURE EP™ System.

The Minneapolis-based Summit Blue Capital is a leader in equipment finance and leasing. It offers tailored leasing and financing solutions for its partners and clients in industries such as healthcare, manufacturing, hospitality, technology solutions, and more. Most notably, Summit Blue Capital specializes in simplifying the financing experience and finding solutions to advance commercial roll outs in the healthcare industry.

“We believe that partnering with Summit Blue Capital will have considerable benefits to our commercial plans. We intend to take advantage of the Summit team’s expertise, flexibility, and financial solutions as a leasing partner,” said Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc. “Summit Blue Capital came highly recommended by one of the largest money center U.S. financial institutions. We believe this relationship will help take friction out of the sales cycle and advance our timeline while allowing BioSig to get paid up front per installation. The team at Summit Blue Capital is expected to also help us launch a subscription-based revenue model for our software.”  

“The pathway to purchase is always of great consideration in the capital equipment forum. We anticipate that partnering with Summit Blue Capital will impact our ability to expedite PURE EP’s entrance into new electrophysiology labs across the United States,” commented Gray Fleming, Chief Commercial Officer of BioSig Technologies, Inc.

“BioSig has made significant improvements to the EP market, and they have a unique technology offering with their PURE EP,” said Adam Drill, President of Summit Blue Capital. “Summit Blue Capital is excited to partner with BioSig and execute on a strategic financing and leasing program that we believe will benefit their customer roll out and help position them as a leader in medical technology. We look forward to helping each other and building a solid foundation for the future.”

The PURE EP™ is an FDA 510(k) cleared non-invasive class II device that aims to drive procedural efficiency and efficacy in cardiac electrophysiology. To date, 75 physicians have completed more than 2,150 patient cases with the PURE EP™ System.

Clinical data acquired by the PURE EP™ System in a multi-center study at Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Mayo Clinic Jacksonville, and Massachusetts General Hospital was recently published in the Journal of Cardiovascular Electrophysiology and is available electronically with open access via the Wiley Online Library. Study results showed 93% consensus across the blinded reviewers with a 75% overall improvement in intracardiac signal quality and confidence in interpreting PURE EP™ signals over conventional sources.

About Summit Blue Capital
Summit Blue Capital is a national commercial finance business based in Minnesota. The Company specializes in custom vendor programs and lease lines-of-credit for companies across the United States. Summit Blue is a privately owned and independently operated finance company that serves all industries. For more information, visit www.summitbluecapital.com.

About BioSig Technologies
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The Company’s first product, PURE EP™ System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Forward-looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Andrew Ballou
BioSig Technologies, Inc.
Vice President, Investor Relations
55 Greens Farms Road
Westport, CT 06880
aballou@biosigtech.com
203-409-5444, x119

Source: BioSig Technologies, Inc.